V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215541 | 20155603 | 1.78 | 89 | null | 2017-07-14 | 2017-07-26 | EOX | 02 | null | EOX | 101168142 |
| 20215542 | 20155604 | 1.91 | 77.9 | Curative (C) | 2017-11-22 | 2017-12-10 | Capecitabine 35days + RT | N | N | EOX | 100610274 |
| 20215544 | 20155605 | 1.69 | 76.2 | Adjuvant (A) | 2018-11-08 | 2019-03-13 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100339859 |
| 20215545 | 20155606 | 1.84 | null | Palliative (P) | 2019-10-05 | 2019-10-13 | Sorafenib | 02 | N | SORAFENIB | 101283128 |
| 20215546 | 20155607 | 1.6 | 68.3 | Palliative (P) | 2020-10-19 | 2021-09-06 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100552892 |
| 20215550 | 20155608 | 1.62 | 55.6 | Palliative (P) | 2019-08-17 | 2019-10-14 | CETUXIMAB + IRINOTECAN + MDG | null | N | CETUXIMAB + IRINOTECAN + MDG | 100579298 |
| 20215551 | 20155609 | 1.78 | 53.4 | Neo-adjuvant (N) | 2019-03-24 | 2020-02-17 | Trial Unspecified | 2 | N | TRIAL | 101422277 |
| 20215552 | 20155610 | 1.57 | 81 | Palliative (P) | 2018-01-25 | 2018-02-14 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100215382 |
| 20215553 | 20155611 | 1.7 | 77.2 | Palliative (P) | 2017-09-20 | 2017-09-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100430302 |
| 20215554 | 20155612 | 1.6 | 47.95 | Palliative (P) | 2019-04-24 | 2019-05-17 | GO2 TRIAL | 02 | N | TRIAL | 100541872 |
| 20215558 | 20155613 | 1.84 | 57 | Curative (C) | 2019-10-08 | 2019-10-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | TRIAL | 100216702 |
| 20215560 | 20155614 | 1.61 | 60 | Palliative (P) | 2017-03-02 | 2018-01-16 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 100034229 |
| 20215563 | 20155615 | 1.63 | 80.45 | Palliative (P) | 2020-04-18 | 2020-05-03 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101600238 |
| 20215566 | 20155616 | 1.69 | 58.4 | Palliative (P) | null | 2020-02-12 | Trial Unspecified | 02 | null | TRIAL | 100445859 |
| 20215570 | 20155617 | 1.86 | 114 | Palliative (P) | 2018-04-01 | 2019-03-11 | EOX | 2 | null | TRIAL | 100498300 |
| 20215572 | 20155618 | 1.65 | 89 | Palliative (P) | 2019-05-06 | 2019-05-09 | EOX | 02 | N | EOX | 100130273 |
| 20215573 | 20155619 | 1.71 | 88.6 | Palliative (P) | 2018-04-21 | 2018-05-07 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100865769 |
| 20215577 | 20155620 | 1.67 | 120 | null | 2019-07-01 | 2019-07-05 | EOX | 02 | N | EOX | 101361849 |
| 20215581 | 20155621 | 1.6 | null | Palliative (P) | 2019-01-11 | 2019-01-11 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101369155 |
| 20215586 | 20155622 | 1.82 | 92.2 | Palliative (P) | 2019-04-13 | 2019-04-13 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100755239 |
| 20215589 | 20155623 | 1.89 | 99.9 | Palliative (P) | 2019-01-16 | 2019-01-24 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100252894 |
| 20215592 | 20155624 | 1.61 | 67.5 | Palliative (P) | 2020-01-18 | 2020-03-06 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100913013 |
| 20215594 | 20155625 | 1.74 | 88.3 | Palliative (P) | 2018-01-29 | 2018-03-17 | Cetuximab + FOLFIRI cycle1 | N | N | CETUXIMAB + IRINOTECAN + MDG | 101626679 |
| 20215597 | 20155626 | 1.72 | 57 | Palliative (P) | 2016-11-03 | 2016-11-28 | Capecitabine 42days + RT | 02 | N | CAPECITABINE + RT | 101181409 |
| 20215603 | 20155627 | 1.78 | 72 | Neo-adjuvant (N) | 2018-05-01 | 2018-05-17 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101105477 |
| 20215604 | 20155628 | 1.72 | 96 | null | 2019-04-15 | 2019-04-22 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101054888 |
| 20215605 | 20155629 | 1.74 | null | Adjuvant (A) | 2019-07-14 | 2020-05-26 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100775031 |
| 20215606 | 20155630 | 0 | 61.7 | Palliative (P) | 2018-02-25 | 2018-04-10 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101215236 |
| 20215607 | 20155631 | 1.53 | 59.5 | Palliative (P) | null | 2017-12-06 | EOX | 02 | N | EOX | 101274518 |
| 20215608 | 20155632 | null | null | Palliative (P) | 2017-04-11 | 2017-05-10 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101485126 |
| 20215609 | 20155633 | 1.83 | 109 | null | 2019-07-06 | 2019-08-10 | EOX | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101630740 |
| 20215612 | 20155634 | 1.88 | 74.5 | Palliative (P) | 2019-03-24 | 2019-06-09 | CETUXIMAB + IRINOTECAN + MDG | 01 | N | CETUXIMAB + IRINOTECAN + MDG | 100671339 |
| 20215618 | 20155635 | 1.64 | 73.9 | Palliative (P) | 2017-01-10 | 2017-02-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101125870 |
| 20215620 | 20155636 | null | 60.6 | Neo-adjuvant (N) | 2017-08-27 | 2018-03-05 | EOX | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 100499947 |
| 20215623 | 20155637 | 1.69 | 76.9 | Neo-adjuvant (N) | 2019-09-27 | 2019-10-12 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100882737 |
| 20215633 | 20155638 | 1.76 | 74.7 | null | 2017-11-26 | 2017-11-26 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100805043 |
| 20215640 | 20155639 | 1.79 | 67.8 | null | 2019-07-01 | 2019-11-08 | EOX | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101635580 |
| 20215641 | 20155640 | 1.6 | 72.9 | Curative (C) | 2019-04-18 | 2019-05-14 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101284793 |
| 20215642 | 20155641 | 1.75 | 75.9 | Neo-adjuvant (N) | 2018-10-27 | 2018-10-28 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101129038 |
| 20215643 | 20155642 | 1.84 | 96.2 | null | 2017-05-06 | 2017-08-13 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100674154 |
| 20215648 | 20155643 | 1.82 | 83 | null | 2019-10-07 | 2020-02-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101541452 |
| 20215652 | 20155644 | 1.67 | 62.9 | Palliative (P) | 2016-01-31 | 2016-08-20 | Sorafenib | 02 | N | SORAFENIB | 100014194 |
| 20215653 | 20155645 | 1.75 | 93 | Palliative (P) | 2016-09-01 | 2016-09-01 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100628543 |
| 20215655 | 20155646 | 1.72 | 96 | Palliative (P) | 2020-12-28 | 2021-01-05 | Sorafenib | 02 | N | SORAFENIB | 100459339 |
| 20215659 | 20155647 | 1.72 | 65 | Palliative (P) | 2018-06-30 | 2018-07-18 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100820050 |
| 20215663 | 20155648 | 1.59 | 64 | Palliative (P) | 2018-01-27 | 2018-01-28 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100108496 |
| 20215665 | 20155649 | 1.6 | 82 | Palliative (P) | 2017-08-15 | 2017-08-24 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101029366 |
| 20215671 | 20155650 | 1.67 | 67.7 | Adjuvant (A) | 2018-04-09 | 2020-02-15 | Trial Unspecified | Y | N | TRIAL | 101362840 |
| 20215674 | 20155651 | 1.84 | null | Palliative (P) | 2019-07-01 | 2019-07-04 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100697678 |
| 20215685 | 20155652 | 1.75 | 70 | null | 2018-01-27 | 2018-02-10 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 101508837 |